All posts by imreal

Karen Lockhart Appointed Chief Operating Officer of In-Flight Crew Connections


News Image

In-Flight Crew Connections has hired Karen Lockhart as their Chief Operating Officer. Lockhart was most recently a Business Consultant who worked closely with the IFCC team to optimize processes and implement strategic initiatives. Moving forward she will continue to collaborate on the strategic direction of the organization, and then bring the vision to life in the business.

“I’m thrilled for Karen to join our team as the Chief Operating Officer. Her experience, proven track record, and synergy with the team here at IFCC will help us achieve our growth goals and continued organizational success,” says IFCC’s CEO Jennifer Guthrie.

Lockhart has an extensive history of proven management skills and planning practices. She brings with her a successful history of simplifying and standardizing business processes in all functional areas, achieving efficient work practices, and greater profitability. At In-Flight Crew Connections Lockhart will direct all departments by supporting the managers and motivating the team to “make our missions possible.”

Share article on social media or email:

Hand and Upper Limb Orthopedic Surgeon Dr. Alejandro Badia Calls Elbow ‘Complex Hinge;’ Offers Tips to Protect It


Dr. Alejandro Badia

Attempting to soften the impact of a fall with outstretched arms, hands open – a natural reaction – may fracture the elbow.

Bracing for bad news may be good defensive strategy but bracing for a fall often is not and may actually end in bad news for upper-limb joints, including the elbow, according to noted orthopedic surgeon Alejandro Badia MD. Attempting to soften the impact of a fall with outstretched arms, hands open – a natural reaction – may fracture the elbow, Dr. Badia indicates. Other causes of elbow injury are a direct blow to the elbow as might occur in sports, car or motorcycle crashes and other trauma or even a simple, low-energy elbow bump.

“The elbow is critical for arm movement. A fracture of that joint may result in significant pain and swelling; limit the arm’s rotation, flexion and extension; cause numbness in the arm or hand; and damage soft tissue or one or more of the major nerves and blood vessels traveling through the elbow,” Dr. Badia says. “Oftentimes, surgery is necessary to repair it.”

In children, elbow fractures, if not properly treated, can hinder bone growth and development, says Dr. Badia, a specialist in treating musculoskeletal disorders of the upper limbs. He is founder and chief medical officer of the Florida-based Badia Hand to Shoulder Center and OrthoNOW®.

Although less frequent than wrist fractures, a break in the elbow often proves more difficult to treat than a broken wrist because of the complexity of the elbow joint, which is a joining of three bones – the upper arm bone, or humerus, that extends from the shoulder to the elbow, and the two forearm bones, radius (on the thumb side of the arm) and ulna (on the ‘pinky” finger side). These bones are connected by ligaments, with muscles and tendons stabilizing the joint and allowing the bones to glide around each other like a well-oiled hinge.

Fractures, which may be accompanied by elbow dislocations, ruptured tendons and ligament tears, can affect almost any part of the elbow joint, including the very tip (olecranon) of the elbow and the epicondyles – the protrusions of the humerus on either side of the elbow. However, epidemiologists say fractures of the radial head – the point where the forearm’s radius meets the humerus bone – are the most common elbow breaks in adults, especially when arms are extended to break a fall.

Treatment varies depending on severity and complexity of the fracture. Non-surgical approaches for small, stable elbow fractures not directly affecting the joint include prescriptive pain medications; placement of the injured arm in a brace, cast or sling to restrict movement; even ultrasound therapy to help bones mend, Dr. Badia says.

However, surgery is the likely recourse for displaced elbow fractures — fractures that force bones out of alignment; open fractures, in which a broken end of bone pierces through the skin; injuries that chip a bone into fragments; or breaks that impact nerves or blood vessels, Dr. Badia says.

A common surgical approach is open reduction-internal fixation, in which the physician realigns the fractured bones and then permanently fixes them in place with screws, plates or stainless-steel wires. A patient may also require a bone graft, often removed from the hip, to replace a bone fragment lost by injury. The graft eventually fuses to the broken elbow bone, forming one piece.

If the elbow fracture is severe enough, particularly in an elderly person and with poor quality bone mass, complete elbow joint replacement (arthroplasty) is now commonly done as the recovery is much easier for the patient with less therapy and a better functional outcome. This is essentially a titanium metal and plastic (polyethelene) hinged joint that restores function as often done in advanced arthritis, Dr. Badia says.

The best therapy is avoiding elbow and other upper-limb fractures entirely. For that reason, Dr. Badia offers these prevention tips:

  • Warm up the body and upper limbs prior to any intense exercise.
  • Use recommended protective gear, such as elbow pads if appropriate, when engaging in sports.
  • Fall-proof the home. Ensure stairway and walkway lighting is adequate inside and outside the house; re-locate loose rugs, cords and other objects that create a tripping risk.
  • Build strong bones through proper nutrition, including foods that offer plenty of calcium. Exercise regularly; stop smoking
  • Maintain a healthy weight and body mass index.

“Should you injure an elbow, avoid the hospital emergency room and, instead, contact an orthopedic specialist,” Dr. Badia emphasizes. It is Important to understand that elbow is a complex area that many orthopedists prefer to refer to an upper extremity/elbow specialist. Important for patients and their families to inquire if complex elbow is a major part of the doctors practice for the more challenging clinical scenarios. “Elbow fractures misdiagnosed or improperly treated can result in malunion of broken bones, joint deformity or permanent nerve damage.”

Alejandro Badia, MD, FACS, internationally renowned hand and upper-limb surgeon and founder of Badia Hand to Shoulder Center and OrthoNOW®, a walk-in orthopedic care clinic. He is a member of the American Society for Surgery of the Hand, American Association for Hand Surgery and the American Academy of Orthopedic Surgeons and an honorary member of many international professional hand societies. Dr. Badia specializes in treating all problems related to the hand and upper extremities, including trauma, sports injury, joint reconstruction, nerve injuries and arthroscopic surgeries. Go to OrthoNOWcare.com and drbadia.com.

Share article on social media or email:

Shoreline Biome Launches New DNA Isolation Product, Shoreline Rapid Prep


News Image

Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, recently unveiled a novel DNA isolation product.

Shoreline Rapid Prep is a fast and easy-to-use kit designed for efficient and unbiased isolation of high molecular weight (HMW) single-stranded DNA (ssDNA) in excess of 40 kB from Gram-negative bacteria, Gram-positive bacteria, and fungi in microbiome samples, cell suspensions, or cell pellets. The ssDNA output is ideal for downstream PCR applications targeting specific bacterial or fungal genes of interest.

The lysis/DNA purification protocol (patent pending) ensures that no microbe is left behind, without the need for cumbersome bead beating, while preserving DNA integrity.

The features of the kit include:


  • Ideal for stool samples and bacterial and vegetative fungal cell isolates
  • Fast and easy: 96 samples ready for PCR in less than 40 minutes
  • Simple automation-ready workflow
  • Superior lysis with no bead beating
  • HMW ssDNA ideal for PCR applications targeting microbial or fungal genes of interest.

The Shoreline Complete line of kits are all-in-one kits that contain the Rapid Prep reagents and all reagents necessary for targeting the V4, V1-V3, V1-V9 or 16S-23S regions for Illumina or PacBio sequencing.

About Shoreline Biome:

Characterizing the human microbiome and analyzing its role in human health and disease are priority goals for researchers around the world. Shoreline Biome accelerates breakthroughs in microbiome research by developing transformative discovery tools that characterize microbiome populations down to the strain level. With Shoreline Biome products, all it takes is three easy steps: lyse, purify, and amplify. Shoreline Biome’s easy-to-use companion analysis software and comprehensive reference database enables straightforward strain-level identification and quantitation of all bacteria in the sample. To learn more, visit shorelinebiome.com.

Share article on social media or email:

Swimming with the SHARKS at RSA Conference!


News Image

LYNX is excited to have been selected for this invitation-only pitch opportunity, and we’re really looking forward to the feedback from “The Sharks”.

L YNX Technology Partners (LYNX), one of Inc. Magazine’s fastest-growing private companies and ranked among the top US security companies for consecutive years, will not only be in attendance at RSA this year, LYNX CEO, Gina Mahin will be ‘Swimming with the Sharks’!

Mahin will be participating in this year’s “Security Shark Tank”. Mahin will make a 15-minute ‘pitch’ to a panel of high-level security decision-makers, moderated by, George Llano, CISO of Deluxe Entertainment.

LYNX is a leader in the fast-growing field of cyber security and risk management; Mahin will be pitching the company’s Integrated Risk Management platform, Lynx Risk Manager (LRM). “LRM goes beyond the traditional, compliance-driven GRC methodology to provide a complete view of risk from across the organization. Imagine having the data at your fingertips that can help quantify risk, justify risk management spending and track the performance of your risk management programs,” shared Mahin. Mahin continued, “We are sharing a look at our IRM platform for the first time, it will certainly be exciting.”

Hosted by Security Current, The Security Shark Tank® during RSA is the premier pitch event of its kind. As Security Current shares, “It draws over 20 CISO buyers from across the country in an informative and fun forum to hear from a select group of invited vendors in a rapid-fire, back and forth pitch.”

“LYNX is excited to have been selected for this invitation-only pitch opportunity, and we’re really looking forward to the feedback from “The Sharks,” indicated Mahin.

The Annual RSA Conference convenes top cybersecurity leaders and a dedicated community of peers to exchange the ‘biggest, boldest ideas that will help propel the industry forward’. The 2020 RSA Conference is being held on Feb. 24-28 in San Francisco.

About Lynx

Lynx Technology Partners delivers dynamic Cyber Security and Risk Management solutions for customers helping them understand and navigate their threat landscape. The Lynx Team is made up of experienced, industry-recognized experts who have led governance, risk management, compliance, and cybersecurity programs and served as subject matter experts (SMEs) for Fortune 500 enterprises and Federal agencies. Lynx combines risk management professional services with an Integrated Risk Management Platform to better manage risk throughout the people, process and technology lifecycle. Dedication to customer success and responsiveness to needs has earned Lynx the trust of a growing list of customers in highly regulated industries worldwide. For more information, please visit LynxTechnologyPartners.com.

Share article on social media or email:

Empower Strengthens Its Position as the Integrated Voltage Regulator (IVR) World Leader


News Image

His impressive track record will be an important part of winning the $6B market opportunity before us. We look forward to Trey’s contributions and leadership as CTO as we define and deliver the industry’s most advanced power management technology

Empower Semiconductor, the world leader in Integrated Voltage Regulators (IVR), today announced the appointment of Trey Roessig, 49, as Chief Technology Officer & SVP Engineering.

Mr. Roessig brings over 20 years of experience and 25 US patents in power and mixed-signal design to the Empower Semiconductor engineering team. Prior to his promotion, Mr. Roessig spearheaded the successful development of Empower’s core technology as SVP of Engineering. Before this he served in senior technology and business roles at Companies such as Integrated Micro Instruments (acquired by Analog Devices) Volterra Semiconductor and ADI. Mr. Roessig holds a Ph.D. in Engineering from the University of California, Berkeley.

“Trey is a proven technology executive with a strong track record of bringing complex, groundbreaking technologies to market. Trey has led Empower’s talented engineering team for two years and demonstrated a world class ability to drive innovation and execution,” said Tim Phillips, Chief Executive Officer and Founder of Empower Semiconductor. “His impressive track record will be an important part of winning the $6B market opportunity before us. We look forward to Trey’s contributions and leadership as CTO as we define and deliver the industry’s most advanced power management technology.”

“I am delighted to take on this expanded role at Empower as we deliver these cutting-edge power management technologies to market,” said Roessig. “Empower’s technical achievements are a testament to the strength of our multi-disciplinary team, and I look forward to helping them accelerate our roadmap in delivering our disruptive power solutions to the market.”

Empower executives will be attending the APEC power conference in New Orleans, March 15-19, 2020. To book meetings at the show with Empower please email your requests to info@empowersemi.com or visit empowersemi.com for more information.

About Empower Semiconductor

Empower Semiconductor
was founded to solve fundamental problems in power delivery for data-intensive applications. Traditional power solutions require dozens of discrete components with big footprints, complex designs and deliver power inefficiently with poor response times and inaccuracies. Empower’s patented IVR technology integrates dozens of components into a single IC increasing efficiency, shrinking footprints by 10x and delivering power with unprecedented simplicity, speed & accuracy and with zero discrete components. This IVR technology addresses a $6B opportunity with a wide range of applications including mobile, 5G, AI and data centers. The company is based in Milpitas, CA and is led by a team of highly experienced power experts and executives.

Empower Semiconductor and the Empower logo are trademarks or registered trademarks of Empower Semiconductor, Inc. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

Share article on social media or email:

Community Health Charities Welcomes Teleangé Thomas to National Board of Directors


“Teleangé’s knowledge and insights will be an invaluable asset as we continue to evolve, building stronger, healthier communities while addressing root causes and inequities.”

Community Health Charities announced today that Teleangé Thomas, Director of Partnerships, Midwest at Candid, joined the CHC national board of directors, adding her significant expertise to an impressive roster of top executives in health and social impact.

“Teleangé has more than 15 years of experience in community engagement and important systems change work,” said Thomas G. Bognanno, Community Health Charities president & CEO. “Her knowledge and insights will be an invaluable asset as we continue to evolve, building stronger, healthier communities while addressing root causes and inequities.”

As Director of Partnerships, Thomas plays a strategic role in elevating Candid’s presence and impact throughout the Midwest, a territory of 13 States (IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, OK, SD, WI). Her direct responsibilities include relationship building, fund development and thought leadership. She is charged with identifying, cultivating and strengthening relationships with primary stakeholders, surfacing regional sector needs and connecting them to Candid products and existing solutions, while contributing to new Candid innovations and piloting new solutions.

She is the co-architect of The Soul of Philanthropy Cleveland and Celebrate Those Who Give Black. These multimedia exhibitions, in conjunction with programming and events, amplify and sharpen the giving power of Black donors and catalyze the next generation of givers and doers, particularly in Cleveland, Ohio.

Thomas is also the founder of Plattforms LLC., a women and minority owned consulting firm that specializes in the design, startup, and sustainability of social change projects and initiatives to improve humanity through socio-economic opportunity and equity-based solutions. The work of Plattforms LLC. is particularly aimed at elevating people, places, and ideas that impact people and communities of color.

Thomas is a graduate of Case Western Reserve University. She is a board of director for Green City Growers, The Conservancy of Cuyahoga Valley National Park, the Cleveland Public Library Foundation and Policy Matters Ohio. She is a Fellow of the Robert Wood Johnson Foundation, a Community Impact Volunteer of the United Way of Greater Cleveland, a member of Zeta-Phi-Beta Sorority Inc. (Inactive), The Order of Eastern Star (Active) and is published in numerous professional journals and academic publications, plus she has earned a host of awards and honors for her service and leadership.

Thomas was elected to the national board of directors by unanimous vote at the last meeting in December and will officially start her Board duties at the next meeting in March, hosted by the Cleveland Cavaliers.

About Community Health Charities

Community Health Charities has been raising awareness and resources and empowering people to take action to improve health and wellbeing for over 60 years. We support education, treatment, and prevention for those with health challenges; bring organizations together to improve community health; provide individuals with opportunities to get involved; and increase the capacity of nonprofit organizations. Visit https://healthcharities.org or @healthcharities.

Share article on social media or email:

Inovi Fertility Launches State-of-the-Art Fertility Lab in Central Houston Location


Inovi Fertility & Genetics Institute, a new boutique fertility clinic located in the heart of Houston, TX, will be launching a state-of-the-art laboratory in February as part of its advanced in vitro fertilization (IVF) and andrology treatment services.

“We are excited to provide the thriving, fast-growing community of Houston with the convenience and unparalleled value of an ultra-modern, on-site fertility laboratory,” said Dr. Stephan Krotz, founder of Inovi. “Our clients will benefit from being able to receive both comprehensive care and innovative lab services all under one roof.”

The Inovi Fertility & Genetics Institute, which has been open and actively seeing patients since last fall, has already distinguished itself by taking an integrative approach towards assisted reproductive techniques (ART). They provide both basic and advanced fertility care, fertility preservation treatments, and third-party reproduction services, including egg donation and surrogacy.

As a boutique clinic, Inovi also offers a full suite of complementary services, such as fertility yoga sessions, as well as access to an extensive reservoir of information and resources. “Our goal is not only to provide our patients with high-quality, advanced care but also to offer them a personalized concierge experience that will support them emotionally during their fertility journey,” Dr. Krotz stated.

Currently, many fertility clinics in the Houston area outsource their laboratory services to medical centers and satellite offices, forcing patients to spend significant time traveling to multiple locations. Not only will Inovi’s integrated laboratory provide a solution to that problem, but their central location makes them easily accessible for the entire Greater Houston metropolitan region.

Built and equipped with the latest cutting-edge technologies, the Inovi laboratories will offer a vast array of diagnostic services and procedures, including:


  • Intrauterine Insemination (IUI)
  • In Vitro Fertilization (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)
  • Preimplantation Genetic Testing (PGT)

Internationally recognized as a progressive reproductive health and fertility expert, Dr. Krotz has a notable history of using advanced technologies and methods to treat infertility. In 2009, he created the first artificial human ovary while at Brown University – a medical achievement that was designated by Time Magazine as one of the “Top 10 Medical Breakthroughs of 2010.” Dr. Krotz, with his experience and ability as an innovator in Reproductive Medicine, and his team are focused on bringing the patient experience to a new level and advancing the delivery of fertility care in Houston and beyond.

Prospective patients in the Greater Houston metropolitan area can start their fertility journey today and take advantage of Inovi’s state-of-the-art boutique facility by setting up an appointment. For more information, visit http://www.inovifertility.com or contact the clinic at (713) 401-9000.

Share article on social media or email:

Velox Clearing LLC Appoints Michael Higgins as Chief Executive Officer


velox-clearing-michael-higgins-new-ceo-clearing-firm-anaheim

CEO, Velox Clearing

The clearing sector is ripe for innovation, and I’m thrilled to be joining an outstanding team that is at the forefront of this movement.

Velox Clearing, LLC (“Velox”), a technology-forward clearing firm, today announced the appointment of brokerage industry veteran Michael Higgins as its Chief Executive Officer.

Mr. Higgins brings three decades of financial services leadership experience to Velox, most recently serving as Head of Operations at LPL Financial (“LPL”). In this position, he oversaw all areas of the firm’s operations while mitigating risk, increasing efficiency, and working to continuously improve the client experience. At LPL, he was also Senior Vice President of Operational Risk Management, where he was responsible for the development and implementation of a risk culture and mitigation methodology throughout the firm’s operational and service organizations. His career to date also encompasses senior-level positions at AXA Equitable, Bank of New York, Pershing, and Charles Schwab.

“The clearing sector is ripe for innovation, and I’m thrilled to be joining an outstanding team that is at the forefront of this movement,” said Higgins. “My industry experience to date has instilled a deep understanding of the challenges and opportunities our clients face, and I look forward to helping Velox and its clients successfully navigate a rapidly evolving landscape to achieve growth.”

In his new role, Mr. Higgins will leverage his broad expertise in brokerage operations, product development, sales, and risk mitigation to drive strategic direction and support Velox’s business development initiatives.

Mr. Higgins earned his Bachelor of Science in Business Management from St. John’s University; he also holds FINRA Series 4, 7, 8, 24, 53, 63 and 65 licenses.

David Herron, former CEO of the Chicago Stock Exchange, and a member of Velox’s board of directors, added: “We are delighted to welcome an executive of Michael’s caliber to the Velox team. Under his expert leadership, we are confident that Velox will continue to deliver exceptional value and differentiated service to clients.”

Southern California-based Velox, which publicly launched operations in 2019, offers securities clearing, settlement, custody, margin lending, stock loan, and prime brokerage solutions to small- to mid-sized broker-dealers, registered investment advisers (RIAs), hedge funds, and automated (black box) traders. The firm introduces superior efficiency and speed to the back-office, supporting its customers’ business operations by combining modern, responsive technology with high-touch service, competitive pricing, and rigorous risk management controls.

About Velox Clearing

Headquartered in Anaheim, CA, Velox Clearing LLC is a technology-forward correspondent clearing firm, prime broker, and RIA custodian. Combining deep expertise, exceptional client service, and cutting-edge technology, Velox empowers its clients to focus on controlling costs, acquiring new business, and leveraging their market presence.

Velox is registered with the SEC, is a member of FINRA and the NYSE, and is a member of DTCC/NSCC and SIPC. For more information, visit http://www.velox-global.com.

Share article on social media or email:

UnitedHealthcare Global’s Isapre Banmédica Receives Award for Improving Care Management in Latin America


MCG Health

MCG Health, part of the Hearst Health network, produces evidence-based, clinical guidance used by nearly 2,000 hospitals and nine of the largest U.S. health plans.

Using evidence-based guidelines as a foundation, we focus on improving the quality of care for those we serve. That reduces unnecessary health care costs and allows more people to get the care they need, when they need it. – Molly Joseph, CEO of UnitedHealthcare Global

Isapre Banmédica, part of UnitedHealthcare Global, has received MCG Health’s 2019 Richard L. Doyle Award.

Isapre Banmédica is one of the largest health plans in Chile, serving more than 850,000 members. Isapre Banmédica is being honored for advancements made in evidence-based clinical care management to improve the efficiency and quality of care for members. Over the course of six months, Isapre Banmédica’s clinical team conducted evidence-based reviews on more than 14,500 hospital admissions. Results during this time included:

  • reducing inappropriate admissions by 43%;
  • improving appropriateness of level of care for patients by 26 percentage points;
  • decreasing the difference between the actual length of stay and evidence-based expected length of stay from 1.92 days to 1.36 days


Isapre Banmédica worked with MCG’s Inpatient & Surgical Care, General Recovery Care, and Ambulatory Care guidelines to help achieve these results.

During this period, use of evidence-based guidelines enriched hospital provider communication, improved practice patterns, and established a baseline from which to compare hospital performance across the system.

“UnitedHealthcare Global keeps clinical quality at the center of everything we do in order to provide the best, most affordable health care to those we serve. Using evidence-based guidelines as a foundation, we focus on improving the quality of care for those we serve. That reduces unnecessary health care costs and allows more people to get the care they need, when they need it,” said Molly Joseph, CEO of UnitedHealthcare Global.

“It’s always reaffirming to see positive impacts from implementing evidence-based practices in health care,” said MCG President and CEO, Jon Shreve. “The results reported by Isapre Banmédica reflect the innovative decision-making of their leaders as well as their passion for improving the health outcomes and experiences of their members.”

This is the fourth time UnitedHealth Group has won the Richard L Doyle Award. In 2010, UnitedHealthcare won for successfully collaborating with hospital surgeons to safely reduce patient readmissions related to gastrointestinal (GI) surgery. Later, in 2016, UnitedHealthcare Global Solutions was recognized for improving quality of care delivery for people traveling and living abroad, and in 2017, UnitedHealthcare’s Amil won the award for improving health outcomes in Brazil. UnitedHealthcare Global is the only international organization to ever win this prestigious award and the only payer organization to win in two years in a row.

The Richard L. Doyle Award will be presented to Isapre Banmédica during MCG’s annual Client Forum in Orlando, Fla., May 17-20, 2020.

About UnitedHealthcare Global

UnitedHealthcare Global offers health plans, services and medical clinical care delivery in countries around the world, serving approximately 8 million unique members enrolled in medical and dental benefit plans. UnitedHealthcare Global operates in Brazil, through Amil, Americas Serviços Médicos and Optum; Chile, Colombia and Peru through Empresas Banmédica and its family of companies; and Portugal, through Lusíadas Saúde. UnitedHealthcare Global provides quality care to patients at 53 hospitals and more than 225 clinics and outpatient centers worldwide.

UnitedHealthcare Global also offers health and well-being solutions in more than 130 countries for employers and individuals who live, work or travel outside their home country. UnitedHealthcare Global is one of the businesses of UnitedHealth Group, a diversified health care company. For more information, visit UnitedHealthcare Global at https://www.uhcglobal.com/.

About Isapre Banmédica

Isapre Banmédica is a health care company with more than 30 years of experience. It serves more than 850,000 beneficiaries throughout Chile, offering a wide range of health plans and additional benefits and services all aimed at generating customized solutions for its customers’ needs.

About MCG Health

MCG, part of the Hearst Health network, helps healthcare organizations implement informed care strategies that proactively and efficiently move people toward health. MCG’s transparent assessment of the latest research and scholarly articles, along with our own data analysis, gives patients, providers, and payers the vetted information they need to feel confident in every care decision, in every moment. For more information visit https://www.mcg.com or follow our Twitter handle at @MCG_Health.

About Hearst Health

The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 99 million home health visits and 3.2 billion dispensed prescriptions. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, MHK (formerly MedHOK—Medical House of Knowledge) and Hearst Health Ventures (http://www.hearsthealth.com). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth or LinkedIn @Hearst-Health.

About the Richard L. Doyle Award for Innovation and Leadership in Healthcare

The Doyle Award was developed to recognize organizations that make innovative use of the care guidelines to help deliver effective healthcare.

Dr. Doyle, the care guidelines founding editor, was a hospital chief-of-staff when he began creating clinical guidelines in the 1980s to help improve healthcare efficiency and quality at Mercy Hospital in San Diego. He later joined Milliman & Robertson and in 1988 published the first set of what was to become the care guidelines.

Judges for this award are independent healthcare quality experts, not currently associated with MCG. Applicants were judged on how well their projects supported the MCG mission to help drive effective care, and the names and locations of the nominees were redacted prior to the judges’ review. Judges looked for evidence of improvements in healthcare quality and patient safety; patient/member satisfaction; staff efficiency, productivity and satisfaction; internal/external communication; and effective use of resources.

Share article on social media or email:



The Charles E. Holman Morgellons Disease Foundation Announces Staging System Developed for Morgellons Disease Based on Experience with Syphilis


News Image

“The staging system will promote recognition and treatment of the disease and ultimately lessen the suffering caused by this challenging illness,” says Stricker.

Morgellons disease is a controversial illness associated with Lyme disease, which is caused by infection with a type of corkscrew-shaped bacteria known as a spirochete. A new study describes a staging system for this mysterious skin disease based on medical experience with syphilis, another spirochete-related infection. The study was published in the prestigious journal Clinical Cosmetic and Investigational Dermatology (https://www.dovepress.com/classification-and-staging-of-morgellons-disease-lessons-from-syphilis-peer-reviewed-article-CCID).

The key diagnostic feature of Morgellons disease is the presence of unusual often colorful filaments found in skin lesions. These characteristic fibers are sometimes incorrectly identified as self-implanted textile fibers in delusional patients. Earlier studies have shown that the filaments are composed of human proteins related to infection with the spirochete that causes Lyme disease, Borrelia burgdorferi. The new study points to similarities between Morgellons disease and the skin pathology seen with Treponema pallidum, the spirochete that causes syphilis.

An international team of collaborators co-authored this important new paper, including microbiologist Marianne Middelveen from Atkins Veterinary Services and pathologist Roberto Martinez from Martinez Veterinary Services, Calgary, Canada; molecular biologists Eva Sapi from University of New Haven, West Haven, CT, USA, and Jennie Burke from Australian Biologics Laboratory, Sydney, Australia; laboratory director Jyotsna Shah from IGeneX Laboratory, Milpitas, CA, USA; clinician Carsten Nicolaus from BCA-Clinic, Augsburg, Germany; and clinicians Melissa Fesler and Raphael Stricker from Union Square Medical Associates, San Francisco, CA, USA.

“The staging system is based on the patterns of Borrelia infection observed in three different stages,” explains Middelveen. According to pathologist Martinez, “The patterns of infection are very specific. I cannot understand how anyone could try to pass this infectious process off as delusional,” he said.

The unusual filaments characteristic of Morgellons disease were shown to originate in deep skin cell layers in response to infection with the Lyme spirochete. In the most severe cases, Borrelia spirochetes are found inside immune cells called macrophages, cells that are normally responsible for detecting, engulfing and destroying pathogens. The new study points to similarities with skin lesions in syphilis.

“At the very least, the emerging body of evidence clearly demonstrates that society is dealing with a poorly defined chronic bacterial infection similar to syphilis that has affected individuals around the globe,” says Stricker. “The staging system will promote recognition and treatment of the disease and ultimately lessen the suffering caused by this challenging illness.”

About the Charles E. Holman Morgellons Disease Foundation:

The Charles E. Holman Morgellons Disease Foundation, based in Austin, TX, is a 501(c) (3) nonprofit organization committed to advocacy and philanthropy in the battle against Morgellons disease. Director, Cindy Casey-Holman, RN, leads the foundation, named for her husband, Charles E. Holman, a pioneer in the fight against Morgellons disease. Currently, there is no public funding and very limited private funding to support research for this disease, and the CEHMDF is the recognized authority and primary funding source for Morgellons disease medical/scientific research. Donations are tax-deductible in the US. To learn more about Morgellons disease go to: http://www.MorgellonsDisease.org

Contact information:

https://thecehf.org/contact-us/

Share article on social media or email: